By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker this week said that it has amended the terms of a credit agreement with JPMorgan Chase Bank, under which the maturity date of its revolving line of credit has been extended to May 24, 2016, and the amount available under the credit facility has been expanded to $250 million. As of May 24, 2011, Bruker had outstanding borrowings under the facility of roughly $185.5 million, while the outstanding principal amount under the term loan facility totaled $105 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.